The public health need and present status of a vaccine for the prevention of coccidioidomycosis

Annals of the New York Academy of Sciences

Volumn 1111, Issue , 2007, Pages 259-268

  Hector, Richard ^a,b   Rutherford, George W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coccidioides; Coccidioidomycosis; Epidemiology; Hospitalization; Immunity; Incidence; Recombinant; Vaccine

Indexed keywords

ANTIGEN; FORMALIN KILLED SPHERULE VACCINE; FUNGUS VACCINE; HYBRID PROTEIN; LIVE VACCINE; PHOSPHORYL LIPID A; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; CONFERENCE PAPER; ETHNICITY; GENDER; HEALTH STATUS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMMUNITY; INCIDENCE; MEDICAL RESEARCH; NONHUMAN; PROTEIN ANALYSIS; RACE; UNITED STATES;

COCCIDIOIDES; MURINAE;

EID: 35348829772     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1406.035     Document Type: Conference Paper

References (42)

1. HECTOR, R.F. & R. LANIADO-LABORIN. 2005. Coccidioidomycosis - a fungal disease of the Americas. PLoS Med. 2: e2.
2. MADDY, K.T. 1958. The geographic distribution of Coccidioides immitis and possible ecologic implications. Ariz. Med. 15: 178.
3. PAPPAGIANIS, D. 1980. Epidemiology of coccidioidomycosis. In Coccidioidomycosis: A Text. D.A. Stevens, Ed. Plenum Publishing Corporation. New York, NY.
4. U.S BUREAU OF THE CENSUS. Population estimates. Available at: http://quickfacts.census.gov/qfd/. Accessed 4 January 2007.
5. PARK, B.J., K. SIGEL, V. VAZ, et al. 2005. An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001. J. Infect. Dis. 191: 1981-1987.
6. COMRIE, A.C. 2005. Climate factors influencing coccidioidomycosis seasonality and outbreaks. Environ. Health Perspect. 113: 688-692.
7. FORSTALL, R.L. California, Population of Counties by Decennial Census. U.S. Bureau of the Census. Available at: www.census.gov/population/ cencounts/ca190090.txt. Accessed September 2, 2005.
8. ROSENSTEIN, N.E., K.W. EMERY, S.B. WERNER, et al. 2001. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin. Infect. Dis. 32: 708-715.
9. FLYNN, N.M., P.D. HOEPRICH, M.M. KAWACHI, et al. 1979. An unusual outbreak of windborne coccidioidomycosis. N. Engl. J. Med. 301: 358-361.
10. PAPPAGIANIS, D. & H. EINSTEIN. 1978. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West. J. Med. 129: 527-530.
11. AMPEL, N.M. 2005. Coccidioidomycosis in persons infected with HIV type 1. Clin. Infect. Dis. 41: 1174-1178.
12. WOODS, C.W., MCRILL C., PLIKAYTIS B.D., et al. 2000. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J. Infect. Dis. 181: 1428-1434.
13. GALGIANI, J.N., AMPEL N.M., BLAIR J.E., et al. 2005. Coccidioidomycosis. Clin. Infect. Dis. 41: 1217-1223.
14. SMITH, C.E. 1958. Coccidioidomycosis. In Preventive Medicine in World War II, Volume IV: Communicable Diseases Chiefly Transmitted through Respiratory and Alimentary Tracts. J. Lada, Ed.: 285-316.U.S. Government Printing Office. Washington, DC.
15. EGEBERG, R.O. 1968. Coccidioidomycosis. In Internal Medicine in World War II, Volume III: Infectious Diseases and General Medicine. R.S. Anderson, W.P. Havens Jr, L.D. Heaton & S. Bayne-Jones, Eds. Office of the Surgeon General, Department of the Army Washington, DC. Available at: http://history.amedd.army.mil/booksdocs/wwii/internalmedicinevolIII/frameindex. html. Accessed 26 December 2006.
16. SMITH, C.E., R.R. BEARD, E.G. WHITING & H.G. ROSENBERGER. 1946. Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases. Am J. Public Health 36: 1394-1402.
17. SMITH, C.E., M.T. SAITO & S.A. SIMONS. 1956. Pattern of 39,500 serologic tests in coccidioidomycosis. JAMA 160: 546-552.
18. VALDIVIA, L., NIX D., WRIGHT M., et al. 2006. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg. Infect. Dis. 12: 958-962.
19. CALIFORNIA DEPARTMENT OF HEALTH SERVICES, DIVISION OF COMMUNICABLE DISEASE CONTROL, TUBERCULOSIS CONTROL BRANCH. Report on Tuberculosis in California, 2003. California Department of Health Services. Richmond, CA, January 2005.
20. SMITH, C.E. & R.R. BEARD. 1946. Varieties of coccidiodal infection in relation to the epidemiology and control of diseases. Am. J. Public Health 36: 1394-1402.
21. PAPPAGIANIS, D., S. LINDSAY, S. BEALL & P. WILLIAMS. 1979. Ethnic background and the clinical course of coccidioidomycosis [letter]. Am. Rev. Resp. Dis. 120: 959-961.
22. CRUM, N.F., M. POTTER & D. PAPPAGIANIS. 2004. Seroincidence of coccidioidomycosis during military desert training exercises. J. Clin. Microbiol. 42: 4552-4555.
23. CRUM, N.F., E.R. LEDERMAN, B.R. HALE, et al. 2003. A cluster of disseminated coccidioidomycosis cases at a U.S. military hospital. Mil. Med. 168: 460-464.
24. CRUM, N., C. LAMB, G. UTZ, et al. 2002. Coccidioidomycosis outbreak among United States Navy SEALs training in a Coccidioides immitis-endemic area - Coalinga, California. J. Infect. Dis. 186: 865-868.
25. WHEELER, G., A. FARAVARDEH, K. DAILY, et al. 2006. A phase II study to evaluate the reactivity and tolerability of intradermally administered doses of coccidioidinin human subjects in a target population. Presented at the American College of Physicians, Army Chapter, National Meeting. Arlington, VA, Nov. 15-18, 2006.
26. LEVINE, H.B., Y.-C KING & C.E. SMITH. 1965. Immunization of mice to Coccidioides immitis: dose, regimen and spherulation stage of killed spherule vaccines. J. Immunol. 94: 132-142.
27. LEVINE, H.B., R.L. MILLER & C.E. SMITH. 1962. Influence of vaccination on respiratory coccidioidal disease in cynomologous monkeys. J. Immunol. 89: 242-251.
28. BARNATO, A.E., G.D. SANDERS & D.K. OWENS. 2001. Cost-effectiveness of a potential vaccine for Coccidioides immitis. Emerg. Infect. Dis. 7: 797-806.
29. PAPPAGIANIS, D. VALLEY FEVER VACCINE STUDY GROUP. 1993. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am. Rev. Resp. Dis. 148: 656-660.
30. DUGGER, K.O., J.N. GALGIANI & N.M. AMPEL. 1991. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect. Immun. 59: 2245-2251.
31. LECARA, G., R.A. COX & R.B. SIMPSON. 1983. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen. Infect. Immun. 39: 473-475.
32. COX, R.A. & D.M. MAGEE. 2004. Coccidioidomycosis: host response and vaccine development. Clin. Microbiol. Rev. 17: 804-839.
33. PAPPAGIANIS, D. 1994. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin. Infect. Dis. 19: S14-S18.
34. PENG, T., L. SHUBITZ, J. SIMONS, et al. 2002. Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice. Infect. Immun. 70: 3330-3335.
35. IVEY, F.D., D.M. MAGEE, M.D. WOITASKE, et al. 2003. Identification of a protective antigen of Coccidioides immitis by expression library immunization.Vaccine 21: 4359-4367.
36. DELGADO, N., XUE J., YU J.J., et al. 2003. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect. Immun. 71: 3010-3019.
37. SHUBITZ, L.F., J.J. YU, C.Y. HUNG, et al. 2006. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine 24: 5904-5911.
38. LERCHE, N.W., D. PAPPAGIANIS, S.M. JOHNSON, et al. 2006. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis). Abstracts of the Sixth International Symposium on Coccidoidomycosis, Stanford, CA, August 23-26.
39. OKEKE, C.N. & G.T. COLE. 2003. Morphological defects and loss of virulence of Coccidioides posadasii caused by disruption of CHS5, encoding a chitin synthase with a myosin motor-like domain [abstract]. Annual Meeting of the American Society of Microbiology, Washington, DC, May 18-22.
40. CHEN, X., C.Y. HUNG & G.T. COLE. 2003. Isolation and characterization of the chitinase gene family of Coccidioides posadasii [abstract]. Annual Meeting of the American Society of Microbiology, Washington, DC, May 18-22.
41. COLE, G.T., J. XUE, C.N. OKEKE, et al. 2004. Avaccine against coccidioidomycosis is justified and attainable. Med. Mycol. 42: 189-216.
42. Notification of Exclusion. Select Agent Program. Centers for Disease Control and Prevention. http://www.cdc.gov/od/sap/sap/exclusion.htm